213 related articles for article (PubMed ID: 10225813)
1. Does sulphasalazine cause drug induced systemic lupus erythematosus? No effect evident in a prospective randomised trial of 200 rheumatoid patients treated with sulphasalazine or auranofin over five years.
Gordon MM; Porter DR; Capell HA
Ann Rheum Dis; 1999 May; 58(5):288-90. PubMed ID: 10225813
[TBL] [Abstract][Full Text] [Related]
2. Development of lupus-related side-effects in patients with early RA during sulphasalazine treatment-the role of IL-10 and HLA.
Gunnarsson I; Nordmark B; Hassan Bakri A; Gröndal G; Larsson P; Forslid J; Klareskog L; Ringertz B
Rheumatology (Oxford); 2000 Aug; 39(8):886-93. PubMed ID: 10952745
[TBL] [Abstract][Full Text] [Related]
3. Predisposing factors in sulphasalazine-induced systemic lupus erythematosus.
Gunnarsson I; Kanerud L; Pettersson E; Lundberg I; Lindblad S; Ringertz B
Br J Rheumatol; 1997 Oct; 36(10):1089-94. PubMed ID: 9374926
[TBL] [Abstract][Full Text] [Related]
4. Antinuclear Antibodies and Lupus-like Manifestations in Rheumatoid Arthritis and Ankylosing Spondylitis Patients at 4 Months' Follow-up After Treatment with Infliximab and Etanercept.
Aghdashi MA; Khadir M; Dinparasti-Saleh R
Curr Rheumatol Rev; 2020; 16(1):61-66. PubMed ID: 31057111
[TBL] [Abstract][Full Text] [Related]
5. Sulphasalazine-induced systemic lupus erythematosus in a patient with rheumatoid arthritis.
Khattak FH; Morris IM; Mattingly PC
Br J Rheumatol; 1996 Jan; 35(1):104. PubMed ID: 8624617
[No Abstract] [Full Text] [Related]
6. Sulphasalazine-induced systemic lupus erythematosus in a patient with erosive arthritis.
Walker EM; Carty JE
Br J Rheumatol; 1994 Feb; 33(2):175-6. PubMed ID: 7909272
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy for rheumatoid arthritis and drug-induced systemic lupus erythematosus.
Borg AA; Davis MJ; Dawes PT; Shadforth MF
Clin Rheumatol; 1994 Sep; 13(3):522-4. PubMed ID: 7835022
[TBL] [Abstract][Full Text] [Related]
8. What is the utility of routine ANA testing in predicting development of biological DMARD-induced lupus and vasculitis in patients with rheumatoid arthritis? Data from a single-centre cohort.
Takase K; Horton SC; Ganesha A; Das S; McHugh A; Emery P; Savic S; Buch MH
Ann Rheum Dis; 2014 Sep; 73(9):1695-9. PubMed ID: 24854356
[TBL] [Abstract][Full Text] [Related]
9. High toxicity of sulfasalazine in adult-onset Still's disease.
Jung JH; Jun JB; Yoo DH; Kim TH; Jung SS; Lee IH; Bae SC; Kim SY
Clin Exp Rheumatol; 2000; 18(2):245-8. PubMed ID: 10812499
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of IgE antinuclear antibodies in rheumatoid arthritis and systemic lupus erythematosus.
Permin H; Wiik A
Acta Pathol Microbiol Scand C; 1978 Oct; 86C(5):245-9. PubMed ID: 309705
[TBL] [Abstract][Full Text] [Related]
11. Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis.
Porter D; Madhok R; Hunter JA; Capell HA
Ann Rheum Dis; 1992 Apr; 51(4):461-4. PubMed ID: 1350192
[TBL] [Abstract][Full Text] [Related]
12. Sulphasalazine-induced autoimmune abnormalities in patients with rheumatic disease.
Borg AA
Br J Rheumatol; 1995 Nov; 34(11):1097-8. PubMed ID: 8542218
[No Abstract] [Full Text] [Related]
13. [Sulphasalazine in patients with rheumatoid arthritis in China: a cross-sectional study].
Liu T; Wang XR; An Y; Zhou YS; Zhang XY; Duan TJ; Zhu JX; Li XF; Wang LZ; Wang CH; Wang YF; Yang R; Wang GC; Lu X; Zhu P; Chen LN; Jin HT; Liu XY; Sun L; Chen HY; Cui LF; Shu R; Liu BL; Zhang ZL; Li GT; Li ZB; Yang J; Li JF; Jia B; Zhang FX; Tao JM; Han SL; Lin JY; Wei MQ; Liu XM; Ke D; Hu SX; Ye C; Yang XY; Li H; Huang CB; Gao M; Lai P; Li XF; Song LJ; Wang Y; Wang XY; Mu R; Su Y; Li ZG
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):188-94. PubMed ID: 22516985
[TBL] [Abstract][Full Text] [Related]
14. Sulphasalazine-induced autoimmune abnormalities in patients with rheumatic disease.
Laversuch CJ; Collins DA; Charles PJ; Bourke BE
Br J Rheumatol; 1995 May; 34(5):435-9. PubMed ID: 7788172
[TBL] [Abstract][Full Text] [Related]
15. Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis.
Haagsma CJ; Blom HJ; van Riel PL; van't Hof MA; Giesendorf BA; van Oppenraaij-Emmerzaal D; van de Putte LB
Ann Rheum Dis; 1999 Feb; 58(2):79-84. PubMed ID: 10343521
[TBL] [Abstract][Full Text] [Related]
16. Sulphasalazine-induced systemic lupus erythematosus.
Mongey AB; Hess EV
Br J Rheumatol; 1994 Aug; 33(8):789-90. PubMed ID: 7914458
[No Abstract] [Full Text] [Related]
17. Efficacy of sulphasalazine plus methotrexate in rheumatoid arthritis.
Islam MN; Alam MN; Haq SA; Moyenuzzaman M; Patwary MI; Rahman MH
Bangladesh Med Res Counc Bull; 2000 Apr; 26(1):1-7. PubMed ID: 11192489
[TBL] [Abstract][Full Text] [Related]
18. [Sulfasalazine: side effects and duration of therapy in patients with rheumatoid arthritis].
Mundo A; Pedone V; Lamanna G; Cervini C
Clin Ter; 1997; 148(1-2):7-13. PubMed ID: 9377840
[TBL] [Abstract][Full Text] [Related]
19. Lack of induction of antinuclear antibodies by D-penicillamine in rheumatoid arthritis: a controlled study.
Weinstein A; Rothfield NF
J Rheumatol; 1986 Apr; 13(2):308-12. PubMed ID: 3487646
[TBL] [Abstract][Full Text] [Related]
20. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial.
Karlsson JA; Neovius M; Nilsson JÅ; Petersson IF; Bratt J; van Vollenhoven RF; Ernestam S; Geborek P
Ann Rheum Dis; 2013 Dec; 72(12):1927-33. PubMed ID: 23196701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
